Subscribe to RSS
DOI: 10.1055/s-2001-16476
© Georg Thieme Verlag Stuttgart · New York
Reversal of Chloroquine and Mefloquine Resistance in Plasmodium falciparum by the Two Monoindole Alkaloids, Icajine and Isoretuline
Publication History
August 18, 2000
December 2, 2000
Publication Date:
17 August 2001 (online)
Abstract
Eight naturally occurring monoindole alkaloids were evaluated in vitro for their ability to inhibit Plasmodium falciparum growth and, in drug combination, to reverse the resistance of a chloroquine-resistant strain of Plasmodium falciparum. None of these indole alkaloids has significant intrinsic antiplasmodial activity (IC50 > 10 μM or 5 μg/ml). Nevertheless, three alkaloids (icajine, isoretuline and strychnobrasiline) did reverse chloroquine resistance at concentrations between 2.5 and 25 μg/ml (IF of 12.82 for isoretuline on W2 strain). The Interaction Factor (IF) equals 2, < 2, or > 2 for additive, antagonistic or synergistic effects of alkaloids on chloroquine inhibition, respectively. Icajine and isoretuline were also assessed in vitro for their mefloquine potentiating activity on a mefloquine-resistant strain of Plasmodium falciparum. Only icajine proved to be synergistic with mefloquine (IF = 15.38).
Key words
Plasmodium falciparum - chloroquine - mefloquine - indole alkaloid
References
- 1 Martin S K, Oduola A M, Milhous W K. Reversal of chloroquine resistance in Plasmodium falciparum by verapamil. Science. 1987; 235 899-901
- 2 Rasoanaivo P, Ratsimamanga-Urverg S, Milijaona R, Rafatro H, Rakoto-Ratsimamanga A, Galeffi C, Nicoletti M. In vitro and in vivo chloroquine-potentiating action of Strychnos myrtoides alkaloids against chloroquine-resistant strains of Plasmodium malaria. Planta Medica. 1994; 60 13-6
- 3 Frédérich M, Hayette M P, Tits M, De Mol P, Angenot L. In vitro activities of Strychnos alkaloids and extracts against Plasmodium falciparum . Antimicrobial Agents and Chemotherapy. 1999; 43 2328-31
- 4 Frédérich M, Tits M, Hayette M P, Brandt V, Penelle J, De Mol P, Llabres G, Angenot L. 10’-Hydroxyusambarensine, a new antimalarial bisindole alkaloid from the roots of Strychnos usambarensis . Journal of Natural Products. 1999; 62 619-21
- 5 Frédérich M, De Pauw-Gillet M C, Llabres G, Tits M, Hayette M P, Brandt V, Penelle J, De Mol P, Angenot L. New antimalarial and cytotoxic sungucine derivatives from Strychnos icaja roots. Planta Medica. 2000; 66 262-9
- 6 Angenot L, Tits M. Isolement d’un nouvel alcaloïde et d’un triterpénoïde à partir du Strychnos henningsii du Zaïre. Planta Medica.. 1981; 41 240-3
- 7 Angenot L, Belem-Pinheiro M L, Imbiriba da Rocha A F, Poukens-Renwart P, Quetin-Leclercq J, Warin R. An indolinic cryptoalkaloid from Strychnos mattogrossensis . Phytochemistry. 1990; 29 2746-9
- 8 Bisset N G, Das B, Parello J. Alkaloids from the leaves of Strychnos icaja Baill. Tetrahedron. 1973; 29 4137-48
- 9 Brandt V, Tits M, Geerlings A, Frédérich M, Penelle J, Delaude C, Verpoorte R, Angenot L. Beta-carboline glucoalkaloids from Strychnos mellodora . Phytochemistry. 1999; 51 1171-6
- 10 Tavernier D, Anteunis M JO, Tits M, Angenot L. The 1H NMR spectra of the Strychnos alkaloids retuline, isoretuline and their N-deacetyl compounds. Bulletin de la Société Chimique Belge. 1978; 87 595-607
- 11 Frédérich M, Tits M, Angenot L. Qualitative and quantitative evaluation of bisindole usambarane alkaloids in Strychnos usambarensis roots by high performance liquid chromatography-diode-array. Phytochemical Analysis. 1998; 9 63-6
- 12 Gadi-Biala R, Tits M, Wauters J N, Angenot L. A new HPLC method for the assay of alkaloids in Strychnos nux-vomica and Strychnos ignatii . Fitoterapia. 1996; 67 163-5
- 13 Trager W, Jensen J B. Human malaria parasites in continuous culture. Science. 1976; 193 673-5
- 14 Desjardins R E, Canfield C J, Haynes J D, Chulay J D. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy. 1979; 16 710-8
- 15 Mirovsky P, Gay F, Bustos D, Mazier D, Gentilini M. Cloning of a fresh isolate of Plasmodium falciparum and drug sensitivity of the clones. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1990; 84 511-5
- 16 Berenbaum M. What is synergy?. Pharmacological Reviews. 1989; 41 93-141
- 17 Loewe S. The problem of synergism and antagonism of combined drugs. Arzneimittelforschung. 1953; 3 285-90
- 18 Frappier F, Jossang A, Soudon J, Calvo F, Rasoanaivo P, Ratsimamanga-Urveg S ,. et al . Bisbenzylisoquinolines as modulators of chloroquine resistance in Plasmodium falciparum and multidrug resistance in tumor cells. Antimicrobial Agents and Chemotherapy. 1996; 40 1476-81
- 19 Bonjean K A, De Pauw-Gillet M C, Quetin-Leclercq J, Angenot L, Bassleer R J. In vitro cytotoxic activity of two potential anticancer drugs isolated from Strychnos: strychnopentamine and usambarensine. Anticancer Research. 1996; 16 1129-37
- 20 Peters W, Robinson B L. The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium . Annals of Tropical Medicine and Parasitology. 1991; 85 5-10
- 21 Oduola A M, Omitowoju G O, Gerena L, Kyle D E, Milhous W K, Sowunmi A, Salako L A. Reversal of mefloquine resistance with penfluridol in isolates of Plasmodium falciparum from south-west Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1993; 87 81-3
Michel Frédérich
Laboratoire de Pharmacognosie
Institut de Pharmacie
Université de Liège
Avenue de l’hôpital 1
CHU du Sart Tilman, B36, tour 4
4000 Liège
Belgium
Email: M.Frederich@ulg.ac.be
Fax: +32 4 366 43 32